ENTA

14.87

0.95% 0.14

Dopo l'orario di chiusura: 14.87

Enanta Pharmaceuticals Inc (ENTA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$14.73

Aprire:

$14.89

Volume 24 ore:

357.44K

Relative Volume:

0.50

Capitalizzazione di mercato:

$429.19M

Reddito:

$66.59M

Utile/perdita netta:

$-104.93M

Rapporto P/E:

-3.004

EPS:

-4.95

Flusso di cassa netto:

$-96.48M

1 W Prestazione:

+4.87%

1M Prestazione:

+23.30%

6M Prestazione:

+98.27%

1 anno Prestazione:

+146.60%

Intervallo 1D:

$14.35

$15.20

Intervallo di 1 settimana:

$13.79

$15.20

Portata 52W:

$4.09

$15.34

Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile

Nome

Enanta Pharmaceuticals Inc

Settore

Healthcare (1131)

Industria

Biotechnology (631)

Telefono

617 607 0800

Indirizzo

4 KINGSBURY AVENUE, WATERTOWN, MA

Dipendente

120

Cinguettio

@EnantaPharma

Prossima data di guadagno

2025-02-10

Ultimi documenti SEC

ENTA's Discussions on Twitter

Confronta ENTA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ENTA Enanta Pharmaceuticals Inc	14.87	425.15M	66.59M	-104.93M	-96.48M	-4.95
VRTX Vertex Pharmaceuticals Inc	455.71	114.69B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	752.62	77.91B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	850.95	54.05B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	391.50	52.52B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	196.92	42.02B	447.02M	-1.18B	-906.14M	-6.1812

Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-11-14	Iniziato	JP Morgan	Overweight
2025-10-01	Aggiornamento	Jefferies	Hold → Buy
2025-07-28	Ripresa	H.C. Wainwright	Buy
2023-08-09	Downgrade	JP Morgan	Neutral → Underweight
2023-08-08	Downgrade	Jefferies	Buy → Hold
2022-12-09	Iniziato	H.C. Wainwright	Buy
2022-07-06	Aggiornamento	Evercore ISI	In-line → Outperform
2022-06-01	Aggiornamento	Evercore ISI	Underperform → In-line
2021-10-07	Iniziato	Jefferies	Buy
2021-09-09	Iniziato	SVB Leerink	Mkt Perform
2021-01-29	Aggiornamento	JP Morgan	Underweight → Neutral
2020-11-24	Iniziato	Evercore ISI	Underperform
2020-08-28	Ripresa	ROTH Capital	Buy
2020-08-26	Iniziato	Piper Sandler	Overweight
2020-07-27	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2020-03-17	Aggiornamento	Robert W. Baird	Neutral → Outperform
2019-11-22	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2019-09-26	Downgrade	JP Morgan	Neutral → Underweight
2019-05-24	Iniziato	Wolfe Research	Outperform
2019-04-23	Aggiornamento	Berenberg	Hold → Buy
2018-12-13	Iniziato	Berenberg	Hold
2018-06-06	Iniziato	ROTH Capital	Buy
2018-02-08	Downgrade	JP Morgan	Overweight → Neutral
2018-01-02	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2017-11-21	Reiterato	RBC Capital Mkts	Outperform
2017-09-15	Iniziato	RBC Capital Mkts	Outperform
2017-07-11	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2016-04-28	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2016-02-09	Reiterato	Barclays	Underweight
2015-10-23	Downgrade	Barclays	Equal Weight → Underweight
2015-10-23	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform

Mostra tutto

Enanta Pharmaceuticals Inc Borsa (ENTA) Ultime notizie

Dec 13, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Share Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat

Dec 13, 2025

Dec 08, 2025

Have Insiders Sold Enanta Pharmaceuticals Shares Recently? - simplywall.st

Dec 08, 2025

Enanta Pharmaceuticals falls on public offering of common stock - MSN

Dec 08, 2025

Dec 06, 2025

Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Scott Rottinghaus Sells 798 Shares - MarketBeat

Dec 06, 2025

Tara Lynn Kieffer Sells 2,106 Shares of Enanta Pharmaceuticals (NASDAQ:ENTA) Stock - MarketBeat

Dec 06, 2025

Enanta Pharma chief medical officer sells $11k in stock By Investing.com - Investing.com Canada

Dec 06, 2025

Insider Selling: Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Sells 1,394 Shares of Stock - MarketBeat

Dec 06, 2025

Dec 05, 2025

Enanta Pharma CBO Luu sells $19,836 in stock By Investing.com - Investing.com Canada

Dec 05, 2025

Enanta Pharma chief product officer sells $30k in stock By Investing.com - Investing.com UK

Dec 05, 2025

Will Enanta Pharmaceuticals Inc. (9EP) stock extend growth storyJuly 2025 Intraday Action & Daily Profit Focused Screening - Newser

Dec 05, 2025

Dec 04, 2025

Can Enanta Pharmaceuticals Inc. (9EP) stock survive global slowdownJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - Newser

Dec 04, 2025

Is Enanta Pharmaceuticals Inc. (9EP) stock nearing a technical breakout - Newser

Dec 04, 2025

Is Enanta Pharmaceuticals Inc. stock a top momentum playQuarterly Market Summary & Risk Controlled Daily Trade Plans - Newser

Dec 04, 2025

Dec 03, 2025

VP Or Surrenders 753 Of Enanta Pharmaceuticals Inc [ENTA] - TradingView

Dec 03, 2025

ENTA: RSV and immunology pipelines advance with key candidates and pivotal trials planned for 2026 - TradingView

Dec 03, 2025

Dec 02, 2025

Is Enanta Pharmaceuticals Inc. (9EP) stock a defensive play amid uncertainty - Newser

Dec 02, 2025

Nov 30, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Nov 30, 2025

Nov 29, 2025

Certain Options of Enanta Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com

Nov 29, 2025

Certain Common Stock of Enanta Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com

Nov 29, 2025

Does Enanta Pharmaceuticals Inc. stock trade at a discount to peersTake Profit & Free Safe Entry Trade Signal Reports - BỘ NỘI VỤ

Nov 29, 2025

Portfolio Recap: What makes Enanta Pharmaceuticals Inc. stock attractive to growth funds2025 Winners & Losers & Risk Adjusted Swing Trade Ideas - moha.gov.vn

Nov 29, 2025

Enanta Pharmaceuticals Inc Stock Analysis and ForecastMarket Capitalization Trends & Free Unmatched Market Performance - earlytimes.in

Nov 29, 2025

Nov 27, 2025